MET
The MET gene, also known as mechanistic target of rapamycin, is a receptor tyrosine kinase involved in embryonic development, wound healing, organ regeneration, and tissue remodeling.
Associated diseases
Papillary renal cell carcinoma, hepatocellular carcinoma, Head and neck cancers
Did you know
MET alterations occur in approximately 1% to 6% of non-small-cell lung cancer (NSCLC) patients
Additional info
The MET gene, also known as mechanistic target of rapamycin, is a receptor tyrosine kinase involved in embryonic development, wound healing, organ regeneration, and tissue remodeling. It regulates proliferation, scattering, morphogenesis, and cellular survival.
